David Owens insider trades
Open-market stock purchases and sales by David Owens, Chief Medical Officer at Nexalin Technology, Inc, from SEC Form 4 filings since Sep 16, 2022.
Track record: 8% of 13 scored buys are up 5% or more since purchase, averaging -55%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 19, 2025 | NXL Nexalin Technology, Inc | Bought (not open market) | — |
Companies traded
- NXL Nexalin Technology, Inc: 13 buys, last Dec 19, 2025